Advanced search
Publication Cover
Emerging Microbes & Infections Volume 9, 2020 - Issue 1
Submit an article Journal homepage
4,148
Views
6
CrossRef citations to date
0
Altmetric
Review Article

Profiles of COVID-19 clinical trials in the Chinese Clinical Trial Registry

Peng Xua Neurology Department, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, People’s Republic of China
,
Xiangyu Xingb Department of Hepatology, The First Hospital of Jilin University, Changchun, People’s Republic of China;c Editorial Department of Journal of Clinical Hepatology, Changchun, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-5122-6446
ORCID Icon,
Keying Yud Cardiovascular Medicine Department, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, People’s Republic of China
,
Zhiguo Lva Neurology Department, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, People’s Republic of China
,
Huijing Cuie Traditional Chinese Medicine Department, Nanguan District Traditional Chinese Medicine Hospital, Changchun, People’s Republic of China
,
Yuhang Shif Department of Gerontology, The Changchun Hospital of TCM, Changchun, People’s Republic of China
,
Tianying Changg GCP Department, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, People’s Republic of China
,
Dongmei Zhangh Scientific Research Office, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, People’s Republic of China
,
Yibin Zhangi College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, People’s Republic of China
,
Kai Wangi College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, People’s Republic of China
,
Jing Luj Research Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, People’s Republic of China
,
Qingxia Huangj Research Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, People’s Republic of China
,
Xiangyan Lik Jilin Ginseng Academy, Jilin Provincial Key Laboratory of BioMacromolecules of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, People’s Republic of China
,
Yingzi Cuig GCP Department, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, People’s Republic of China
,
Li Shil Respiratory Medicine Department, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, People’s Republic of China
,
Tan Wangl Respiratory Medicine Department, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, People’s Republic of China
,
Junqi Niub Department of Hepatology, The First Hospital of Jilin University, Changchun, People’s Republic of ChinaCorrespondence[email protected]
&
Jian Wanga Neurology Department, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 1695-1701 | Received 01 Apr 2020, Accepted 30 Jun 2020, Published online: 22 Jul 2020

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hui Zhang, Zhiping Guo, Lijun Shen, Yongguang Yang, Zhenxiang Zhang & Yuming Wang. (2021) What Can We Learn from COVID-19 Drug Development and Access for Non-Pandemic Diseases? A Chinese Perspective. The American Journal of Bioethics 21:12, pages 42-45.
Read now

Articles from other publishers (5)

Ashuai Du, Rong Zheng, Cyrollah Disoma, Shiqin Li, Zongpeng Chen, Sijia Li, Pinjia Liu, Yuzheng Zhou, Yilun Shen, Sixu Liu, Yongxing Zhang, Zijun Dong, Qinglong Yang, Moyed Alsaadawe, Aroona Razzaq, Yuyang Peng, Xuan Chen, Liqiang Hu, Jian Peng, Qianjun Zhang, Taijiao Jiang, Long Mo, Shanni Li & Zanxian Xia. (2021) Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2. International Journal of Biological Macromolecules 176, pages 1-12.
Crossref
Xiaodan Li, Shengzhao Zhang, Yiling Zhou, Ying Liu, Youlian Zhou, Sheyu Li & Na Su. (2021) Deficiencies in Planning Interventional Trial Registration of COVID-19 in China. Frontiers in Medicine 8.
Crossref
Mingxu Zhang, Ju Huang, Xinhui Wu, Lizeyu Lv, Anming Huang & Siquan Zhu. (2020) Internal treatment in traditional Chinese medicine for patients with COVID-19. Medicine 99:51, pages e23739.
Crossref
Luca Falciola & Massimo Barbieri. (2020) Searching and Analyzing Patent-Relevant Information for Evaluating COVID-19 Innovation. SSRN Electronic Journal.
Crossref
N Vasantha Raju & N.S. Harinarayana. (2020) Indian Clinical Trials on COVID-19: A Review of Clinical Trials Registry of India (CTRI). SSRN Electronic Journal.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.